biotech
Blackstone puts $250M into Anagram to tackle cystic fibrosis complication
Endpoints News
May 11, 2026 · 18s listen
Listen · Endpoints News
Blackstone puts $250M into Anagram to tackle cystic fibrosis complication
0:00-0:18
Live · Kokoro-82M
Audio pre-rendered by Storyflo · cached + delivered from the edge
Blackstone Life Sciences, fresh off one of the largest private investment funds in industry history, is putting $250 million to work on a little-known biotech seeking to drastically reduce the number of ...
Share
Send this story to anyone — or drop the embed into a blog post, Substack, Notion page. Every play sends rev-share back to Endpoints News.
Heard via Storyflo
Get audio versions of every article you read.
Pick what matters — your audio curator gets you into your daily flo.